Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mindscape is a private mental health services company focused on ketamine-based treatment for mood disorders and chronic pain. Historically, the company operated as MindScape Ketamine & Infusion Therapy, a Houston-based clinic offering intravenous ketamine therapy and virtual reality-guided meditation. Its current consumer-facing business appears to operate as The Mindscape, which connects patients with licensed clinical and pharmacy partners for personalized at-home ketamine treatment, including compounded oral troches and nasal spray options where clinically appropriate. The company targets conditions such as depression, anxiety, PTSD, and related mental health disorders, emphasizing personalized protocols and supportive patient engagement. It is a healthcare services business rather than a drug developer, and no proprietary therapeutic pipeline was identified.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mindscape.